GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight ...

People are central to our success. That’s why we offer benefits focused on supporting your comprehensive well-being—both inside and outside of work. Our benefits vary by region, but the goal is the ...

Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories ...

People with pre-existing depression or anxiety were less likely to have mental health worsening while taking a GLP-1 ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

Oral semaglutide improved multiple cardiometabolic metrics among adults with type 2 diabetes at high risk for atherosclerotic ...

Durability through 156 weeks favored semaglutide for HbA1c (−0.47%), weight (−3.26%), systolic BP (−1.83 mm Hg), and pulse ...

By now you’ve heard plenty of buzz about GLP-1 medications like Ozempic, Wegovy and Zepbound. Originally developed for type 2 ...

GLP-1 receptor agonists like semaglutide, known as Ozempic and Wegovy, have been linked to lower rates of worsening ...